TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance
Journal of Experimental Medicine · 2023
DOI: 10.1084/jem.20230944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2023. Verfasst von Elif Çakan und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Platelet Factor 4, Scleroderma, Systemic, Toll-Like Receptor 9. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Central B cell tolerance is believed to be regulated by B cell receptor signaling induced by the recognition of self-antigens in immature B cells. Using humanized mice with defective MyD88, TLR7, or TLR9 expression, we demonstrate that TLR9/MYD88 are required for central B cell tolerance and the removal of developing autoreactive clones. We also show that CXCL4, a chemokine involved in systemic sclerosis (SSc), abrogates TLR9 function in B cells by sequestering TLR9 ligands away from the endosomal compartments where this receptor resides. The in vivo production of CXCL4 thereby impedes both TLR9 responses in B cells and the establishment of central B cell tolerance. We conclude that TLR9 plays an essential early tolerogenic function required for the establishment of central B cell tolerance and that correcting defective TLR9 function in B cells from SSc patients may represent a novel therapeutic strategy to restore B cell tolerance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
- HSS Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery , New York, NY, USA.
- Department of Clinical Immunology, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Medicine, Weill Cornell Medical College of Cornell University, New York, NY, USA.
- Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Department of Medicine, University of Massachusetts School of Medicine, Worcester, MA, USA.
ORCID-Profile: Elif Çakan, Marie Dominique Ah Kioon, Yolanda Garcia-Carmona, Salomé Glauzy, David Oliver, Natsuko Yamakawa, Yong Du, Jean-Nicolas Schickel, Joshua M Boeckers, Chao Yang, Alessia Baldo, Lionel B Ivashkiv, Ryan M Young, Louis M Staudt, Kerstin Nündel, Ann Marshak-Rothstein, Caspar I van der Made, Alexander Hoischen, Anthony Hayward, Marzia Rossato, Timothy R D J Radstake, Charlotte Cunningham-Rundles, Changwan Ryu, Erica L Herzog, Franck J Barrat, Eric Meffre
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Scleroderma Research Foundation
- National Heart, Lung, and Blood Institute
Zitieren
APA
Çakan, E., Ah Kioon, M. D., Garcia-Carmona, Y., Glauzy, S., Oliver, D., Yamakawa, N., Vega Loza, A., Du, Y., Schickel, J. N., Boeckers, J. M., Yang, C., Baldo, A., Ivashkiv, L. B., Young, R. M., Staudt, L. M., Moody, K. L., Nündel, K., Marshak-Rothstein, A., van der Made, C. I., …, & Meffre, E. (2023). TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20230944
Vancouver
Çakan E, Ah Kioon MD, Garcia-Carmona Y, Glauzy S, Oliver D, Yamakawa N, et al. TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance. Journal of Experimental Medicine. 2023. doi:10.1084/jem.20230944
BibTeX
@article{akan2023,
author = {Çakan, Elif and Ah Kioon, Marie Dominique and Garcia-Carmona, Yolanda and Glauzy, Salomé and Oliver, David and Yamakawa, Natsuko and Vega Loza, Andrea and Du, Yong and Schickel, Jean-Nicolas and Boeckers, Joshua M and Yang, Chao and Baldo, Alessia and Ivashkiv, Lionel B and Young, Ryan M and Staudt, Louis M and Moody, Krishna L and Nündel, Kerstin and Marshak-Rothstein, Ann and van der Made, Caspar I and Hoischen, Alexander and Hayward, Anthony and Rossato, Marzia and Radstake, Timothy R D J and Cunningham-Rundles, Charlotte and Ryu, Changwan and Herzog, Erica L and Barrat, Franck J and Meffre, Eric},
title = {TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance},
journal = {Journal of Experimental Medicine},
year = {2023},
doi = {10.1084/jem.20230944}
}
EUVIMED